Pfizer says vaccine safe, effective in 12- to 15-year-olds after clinical trial

Pfizer-BioNTech says its vaccine is safe and showed 100 per cent efficacy in a clinical trial of 12- to 15-year-olds. Health officials say more data is needed, but parents are optimistic about the results.